NEW YORK, April 28, 2025--(BUSINESS WIRE)--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare ...

EXCLUSIVE: In a competitive situation, Fox has landed Therapy Dog, an animated comedy with a script plus presentation commitment. It hails from writer-producer-actress Sharon Horgan (Catastrophe, ...

Surgery alone may not be an effective treatment approach for patients with lung cancer due to potential microscopic cancer spread — or micrometastatic disease, which opens up the conversation to using ...

NEW HOPE, Pa., March 13, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to ...

While there is still no cure for multiple myeloma, CAR-T cell therapy offers patients with previously treated myeloma “unprecedented” outcomes, according to Dr. Surbhi Sidana, assistant professor of ...

Although primary PCI is the preferred approach for the majority of patients if it can be performed by an experienced operator and within 90 minutes of time-to-balloon, access to such resources tends ...

Oral Presentation on Saturday to Highlight Interim Safety and Efficacy Results from the MyPEAK™-1 Phase 1b/2a Clinical Trial in Adults with MYBPC3-Associated Hypertrophic Cardiomyopathy Second ...

The Farmer to Farmer Program of Partners of the Americas is inviting the general public to a presentation on the importance of Horticultural Therapy According to a Partners of the Americas release, ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Arsenal Biosciences, Inc. (ArsenalBio), a clinical stage programmable cell therapy company engineering advanced CAR T-cell therapies for solid tumors, ...

EXCLUSIVE: Lisa Kudrow is set to voice the title character in Therapy Dog, Fox‘s animated presentation from writer-producer-actress Sharon Horgan, actress Clea DuVall, writer-producers Jennifer ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catamaran Bio, Inc., a biotechnology company developing off-the-shelf CAR-NK cell therapies to treat cancer, today announced that it has designated CAT-179, a ...